Omitting Radiation Therapy From Breast Cancer Treatment May Be Possible for Younger Post-Menopausal Women With Early-Stage HR-Positive/HER2-Negative Breast Cancer

A clinical trial suggests younger post-menopausal women with early-stage HR-positive/HER2-negative breast cancer may safely omit radiation therapy if they continue endocrine therapy.

Related Keywords

San Antonio ,Texas ,United States ,Reshma Jagsi ,Lawrencew Davis ,Emory University School Of Medicine ,San Antonio Breast Cancer Symposium ,Radiation Oncology ,Emory University School ,Winship Cancer Institute ,Emory University ,